W D Beecken Selected Research

O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)

10/2001	Inhibition of inflammatory corneal angiogenesis by TNP-470.
3/2001	Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
2/2001	Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor.
9/2000	Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W D Beecken Research Topics

Disease

6	Neoplasms (Cancer) 10/2004 - 09/2000
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2001 - 09/2000
2	Carcinoma (Carcinomatosis) 02/2001 - 09/2000
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2001
1	Body Weight (Weight, Body) 10/2001
1	Corneal Neovascularization 10/2001
1	Liposarcoma 07/2001
1	Neoplasm Metastasis (Metastasis) 03/2001
1	Lewis Lung Carcinoma 03/2001
1	Transitional Cell Carcinoma 09/2000

Drug/Important Bio-Agent (IBA)

4	Angiogenesis InhibitorsIBA 10/2001 - 02/2001
4	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 10/2001 - 09/2000
2	EnzymesIBA 07/2001 - 03/2001
2	SuspensionsIBA 07/2001 - 02/2001
2	AngiostatinsIBA 03/2001 - 03/2001
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2004
1	Methylcellulose (BFL)IBA 10/2001
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2001
1	salicylhydroxamic acid (SHAM)IBA 03/2001
1	fumagillolIBA 09/2000
1	Phosphates (Orthophosphate)IBA 09/2000

Therapy/Procedure

4	Therapeutics 11/2001 - 09/2000
1	Debridement 10/2001
1	Drug Therapy (Chemotherapy) 03/2001
1	Radiotherapy 03/2001